Article Text

Download PDFPDF
OC-027 Use of Buccal Vitamin D Supplementation in Patients with Short Bowel Syndrome
  1. GJH Thomson,
  2. C Mountford,
  3. N Thompson
  1. Newcastle Upon Tyne Hospitals, Newcastle Upon Tyne, UK


Introduction Vitamin D (vit D) deficiency is a common consequence of short bowel syndrome and can detrimentally affect bone and muscle health. Oral vit D supplements can be absorbed variably and parenteral supplementation does not always result in improved serum levels.1 We wished to see if buccal vit D supplementation represents a useful alternative?

Methods Patients with short bowel syndrome who had not responded to high dose oral vit D supplementation and were prescribed buccal vit D spray (“Dlux3000” BetterYou(TM)) were identified through the regional nutrition service (n = 13). This cohort was 46.2% female and 53.8% male with a mean age of 52.7 years. Accurate measurements of all participants small bowel functionality were not available, however, 7 were recorded as having less than 100 cm of small bowel remaining. Not all participants were reliant on parenteral nutrition (n = 7), those who were(n = 6) received between 10 and 15 L parenteral nutrition per week. Participants were prescribed between 3000 and 9000 iu/day. 25(OH) vit D was used to measure vit D status. Baseline levels were obtained prior to when buccal vit D was prescribed. This was compared with the level obtained at their next clinic appointment, at least one month later. For analysis a paired t test was undertaken in two groups; A, including (n = 13), and B excluding (n = 8), patients using other vitamin D supplements concurrently. Of those in group B 75% had previously been prescribed oral vit D supplements without achieving vit D sufficiency.

Results Group A: Mean baseline 25(OH)D was 22.3 ng/ml, 95%CI (18.1,26.5) (. Buccal vit D supplementation increased this to an average of 61.4 ng/ml, 95%CI (44.7, 78.1). This increase proved to be statistically significant (p =< 0.05) and suggests that buccal vit D either alone or as an adjunct to oral supplements produces a significant rise in vit D level from that of deficiency to sufficiency.

Group B: Mean baseline 25(OH)D was 21.9 ng/ml, 95%CI (18.3, 25.4). Using buccal vit D spray alone mean 25(OH)D was increased to 53 ng/ml, 95%CI (43.2, 62.8) (p =< 0.05). This suggests that buccal vit D monotherapy may be sufficient to achieve adequate vit D levels in those patients who have not responded to oral supplements.

Conclusion This study provides preliminary evidence from a small number of patients that buccal vit D spray may be an effective adjunct to oral vit D supplementation or be an effective monotherapy in short bowel patients who do not respond adequately to oral supplements. Further investigation into buccal vit D spray is warranted.

Reference 1 Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011;86(1):50–60. 10.4065/mcp.2010.0567

Disclosure of Interest G. Thomson: None Declared, C. Mountford: None Declared, N. Thompson Conflict with: BSG secretary

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.